Building a Better Picture of Cancer
Clinical labs are adopting broader cancer diagnostics—including whole-genome sequencing and multi-omic testing—to deliver more comprehensive molecular insights and improve disease monitoring.
Read MorePosted by CLP Edit Staff | Aug 4, 2026 | Cancer, Lab Automation, Molecular Diagnostics |
Clinical labs are adopting broader cancer diagnostics—including whole-genome sequencing and multi-omic testing—to deliver more comprehensive molecular insights and improve disease monitoring.
Read MorePosted by CLP Edit Staff | Jul 31, 2026 | Leukemia |
Nabsys and Indiana University School of Medicine have launched a multi-year collaboration to develop electronic genome mapping applications for acute myeloid leukemia and myelodysplastic syndromes.
Read MorePosted by CLP Edit Staff | Jul 6, 2026 | Cancer, Company News, Molecular Diagnostics |
The test utilizes genomic sequencing and AI to identify biological signals associated with early-stage disease.
Read MorePosted by CLP Edit Staff | Jun 4, 2026 | Cancer, Leukemia, Molecular Diagnostics |
Research shows optical genome mapping identifies genomic changes in nearly 98% of T-cell acute lymphoblastic leukemia cases compared to 55% with traditional analysis.
Read MorePosted by CLP Edit Staff | Apr 21, 2026 | Leukemia, Molecular Diagnostics |
Optical genome mapping detected clinically significant genetic variants missed by standard tests in nearly 20% of acute leukemia cases, according to a 200-patient study.
Read More